| Literature DB >> 27340094 |
Seo-Yong Lee1, Mi-Kyeong Ko2, Kwang-Nyeong Lee2, Joo-Hyung Choi2, Su-Hwa You2, Hyun-Mi Pyo2, Myoung-Heon Lee2, Byounghan Kim2, Jong-Soo Lee3, Jong-Hyeon Park4.
Abstract
Efficacy evaluation of foot-and-mouth disease (FMD) vaccines has been conducted in target animals such as cows and pigs. In particular, handling FMD virus requires a high level of biosafety management and facilities to contain the virulent viruses. The lack of a laboratory animal model has resulted in inconvenience when it comes to using target animals for vaccine evaluation, bringing about increased cost, time and labor for the experiments. The FMD mouse model has been studied, but most FMD virus (FMDV) strains are not known to cause disease in adult mice. In the present study, we created a series of challenge viruses that are lethal to adult C57BL/6 mice. FMDV types O, A, and Asia1, which are related to frequent FMD outbreaks, were adapted for mice and the pathogenesis of each virus was evaluated in the mouse model. Challenge experiments after vaccination using in-house and commercial vaccines demonstrated vaccine-mediated protection in a dose-dependent manner. In conclusion, we propose that FMD vaccine evaluation should be carried out using mouse-adapted challenge viruses as a swift, effective efficacy test of experimental or commercial vaccines.Entities:
Keywords: Challenge; Evaluation; Foot-and-mouth disease; Mouse FMD model; Mouse-adapted FMDV; Vaccine
Mesh:
Substances:
Year: 2016 PMID: 27340094 DOI: 10.1016/j.vaccine.2016.06.008
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641